Loading...
Please wait, while we are loading the content...
A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Haghiralsadat, Fateme Amoabediny, Ghasem Helder, Marco N. Naderinezhad, Samira Sheikhha, Mohammad Hasan Forouzanfar, Tymour Zandieh-Doulabi, Behrouz |
| Copyright Year | 2018 |
| Abstract | This study focuses on the development of a universal mathematical model for drug release kinetics from liposomes to allow in silico prediction of optimal conditions for fine-tuned controlled drug release. As a prelude for combined siRNA-drug delivery, nanoliposome formulations were optimized using various mole percentages of a cationic lipid (1,2-dioleoyl-3-trimethylammonium-propane, DOTAP) in the presence or absence of 3 mol% distearoyl phosphoethanolamine, polyethylene glycol (PEG-2000mDSPE). Outcome parameters were particle size, zeta potential, entrapment efficiency, in vitro drug release, and tumor cell kill efficiency. The optimized formula (containing 20% DOTAP with 3% DSPE-mPEG(2000) was found to be stable for six months, with round-shaped particles without aggregate formation, an average diameter of 71 nm, a suitable positive charge, and 89% drug encapsulation efficiency (EE). The 41% drug release during 6 h confirmed controlled release. Furthermore, the release profiles as functions of pH and temperature were investigated and the kinetics of the drug release could adequately be fitted to Korsmeyer-Peppas' model by multiple regression analysis. The statistical parameters confirmed good conformity of final models. Functionality of the novel cationic liposome formulations (± DOX) was tested on osteosarcoma (OS) cell lines. Increased OS cell toxicity (1.3-fold) was observed by the DOX-loaded vs. the free DOX. A feasibility pilot showed that siRNA could be loaded efficiently as well. In conclusion, we have established a predictive mathematical model for the fine-tuning of controlled drug release from liposomal formulations, while creating functional drug-delivery liposomes with potential for siRNA co-delivery to increase specificity and efficacy. |
| Starting Page | 169 |
| Ending Page | 177 |
| Page Count | 9 |
| File Format | PDF HTM / HTML |
| DOI | 10.1080/21691401.2017.1304403 |
| PubMed reference number | 28376641 |
| Journal | Medline |
| Volume Number | 46 |
| Issue Number | 1 |
| Alternate Webpage(s) | http://ut.ac.ir/file/download/news/1508057019-sadat-article4.pdf |
| Alternate Webpage(s) | https://doi.org/10.1080/21691401.2017.1304403 |
| Journal | Artificial cells, nanomedicine, and biotechnology |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |